효소 처리 감태 추출물을 포함하는 피부 미백용 조성물
    61.
    发明公开
    효소 처리 감태 추출물을 포함하는 피부 미백용 조성물 审中-实审
    用于皮肤刺激的组合物,包括通过酶处理的ECKLONIA CAVA的提取物

    公开(公告)号:KR1020130017159A

    公开(公告)日:2013-02-20

    申请号:KR1020110079436

    申请日:2011-08-10

    Abstract: PURPOSE: A composition containing an Ecklonia cava extract treated with an enzyme and a method for manufacturing the same are provided to suppress tyrosinase and melanogenesis. CONSTITUTION: A composition for skin whitening contains 0.001-20 wt% of an Ecklonia cava extract treated with an enzyme as an active ingredient. The enzyme is a cell wall degrading enzyme including celluclast or protease including pectinase. The composition is a cosmetic composition or a pharmaceutical composition. A method for preparing the composition comprises: a step of treating Ecklonia cava with an enzyme; and a step of extracting the enzyme-treated Ecklonia cava with water, an organic solvent, or a mixture thereof.

    Abstract translation: 目的:提供含有用酶处理的Ecklonia cava提取物及其制备方法的组合物以抑制酪氨酸酶和黑素生成。 构成:用于皮肤美白的组合物含有用酶作为活性成分处理的Ecklonia cava提取物的0.001-20重量%。 酶是细胞壁降解酶,包括果胶酶或蛋白酶,包括果胶酶。 该组合物是化妆品组合物或药物组合物。 一种制备该组合物的方法包括:用酶处理Ecklonia cava的步骤; 以及用水,有机溶剂或其混合物提取经酶处理的埃克氏杆菌的一个步骤。

    신규 벤조산아미드 화합물
    62.
    发明公开
    신규 벤조산아미드 화합물 有权
    新颖的苯甲酸化合物

    公开(公告)号:KR1020130015954A

    公开(公告)日:2013-02-14

    申请号:KR1020110078309

    申请日:2011-08-05

    Abstract: PURPOSE: A benzoic acid amide compound is provided to have excellent a skin-whitening effect without side effects by suppressing melanin generation and decreasing tyrosinase activity. CONSTITUTION: A benzoic acid amide compound, an isomer thereof, pharmaceutically-acceptable salt thereof, a prodrug thereof, a hydrate thereof, or a solvate thereof is represented by chemical formula 1. In the chemical formula 1: each of R1, R3, and R4 is independently selected from hydrogen, hydroxy, C1-C5 alkoxy, C3-C6 cycloalkoxy, aryloxy, and C1-C15 haloalkoxy; R2 is selected from hydrogen, C1-C5 alkyl, C3-C6 cycloalkyl, aryl, and C1-C5 haloalkyl; and n is an integer from 1-5.

    Abstract translation: 目的:提供苯甲酸酰胺化合物以通过抑制黑色素产生和降低酪氨酸酶活性而具有优异的美白效果而没有副作用。 构成:化学式1表示苯甲酸酰胺化合物,其异构体,药学上可接受的盐,其前药,其水合物或其溶剂合物。在化学式1中,R1,R3和 R 4独立地选自氢,羟基,C 1 -C 5烷氧基,C 3 -C 6环烷氧基,芳氧基和C 1 -C 15卤代烷氧基; R2选自氢,C1-C5烷基,C3-C6环烷基,芳基和C1-C5卤代烷基; n为1-5的整数。

    유색콩 추출물을 함유하는 조성물
    63.
    发明公开
    유색콩 추출물을 함유하는 조성물 无效
    包含色素提取物的组合物

    公开(公告)号:KR1020110138000A

    公开(公告)日:2011-12-26

    申请号:KR1020100058067

    申请日:2010-06-18

    CPC classification number: A61K36/48

    Abstract: PURPOSE: An antithrombotic composition containing colored bean extract and fraction thereof is provided to contain adenosine and to treat cardiovascular and cerebralvascular diseases and hypertension. CONSTITUTION: An antithrombotic composition contains colored bean extract isolated using water, C1-C5 alcohol, or mixture thereof and organic acid. The organic acid includes citric acid, acetic acid, butyric acid, palmitic acid, oxalic acid, tartaric acid, carboxylic acid, or sulfonic acid. The C1-C5 alcohol is methane, ethanol, isopropylalcohol, n-propyl alcohol, n-butanol, or isobutanol. A fraction of the extract is prepared by fractioning the alcohol extract of colored beans using a synthetic adsorption column containing polystylene and benzene polymers.

    Abstract translation: 目的:提供含有彩色豆提取物及其级分的抗血栓形成组合物,用于含有腺苷并治疗心血管和脑血管疾病和高血压。 构成:抗血栓组合物含有使用水,C1-C5醇或其混合物和有机酸分离的有色豆提取物。 有机酸包括柠檬酸,乙酸,丁酸,棕榈酸,草酸,酒石酸,羧酸或磺酸。 C1-C5醇是甲烷,乙醇,异丙醇,正丙醇,正丁醇或异丁醇。 通过使用含有聚苯乙烯和苯聚合物的合成吸附塔对有色豆的醇提取物进行分级来制备提取物的一部分。

    극성 비양자성 용매를 이용한 N-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법
    69.
    发明公开
    극성 비양자성 용매를 이용한 N-[4-(1-아미노에틸)-페닐]-술폰아미드 유도체의 카이랄 분할 방법 审中-实审
    用极性非质子溶剂手性拆分N- [4-(1-氨基乙基) - 苯基] - 磺酰胺衍生物的方法

    公开(公告)号:KR1020170081315A

    公开(公告)日:2017-07-12

    申请号:KR1020160000212

    申请日:2016-01-04

    CPC classification number: C07C303/36 C07C311/08 C07D213/26 C07D213/61

    Abstract: 본명세서는비대칭탄소원자에아민기가결합된화합물의입체이성질체혼합물을카이랄보조체와혼합시키는단계를포함하는입체이성질체혼합물의카이랄분할방법에관한것이다. 이때, 카이랄보조체는 2,3-디벤조일-타르타르산또는-디--톨루오일타르타르산이고, 이러한방법에의하면높은수준의광학순도를가지는광학이성질체를얻는것이가능하다. 또한, 이러한방법에의하면광학이성질체를회수하여모액에포함된입체이성질체혼합물의비율을조절하는것이가능하다. 따라서, 본발명의일 측면에따른방법은약학또는제약분야에서단일한형태의광학이성질체를가지는화합물을높은순도로수득하고자하는경우에유용하게사용될수 있으며, 다른반응에서사용된모액을라세미화하는데유용하게사용될수 있다.

    Abstract translation: [0011]本申请公开了胺基团键合到的不对称碳原子以立体异构体混合物的手性拆分方法,包括手性辅助体和混合的步骤的化合物的立体异构混合物。 在这种情况下,手性辅助体是2,3-二苯甲酰基 - 它能够获得甲苯甲酰酒石酸,根据该方法具有高度的光学纯度的光学异构体 - 酒石酸或α-d。 另外,根据该方法,可以回收光学异构体以控制母液中所含立体异构体混合物的比例。 因此,根据本发明的一方面,该方法可有效地,如果期望得到具有单一hanhyeongtae在药物或药物与高纯度的光学异构体,对母液中的不同反应中使用的外消旋化有用的化合物采用 它可以被使用。

Patent Agency Ranking